文献速递炎症性肠病胰腺与胆道疾病

全国性队列研究:炎症性肠病增加2型糖尿病风险

Inflammatory Bowel Diseases Increase Risk of Type 2 Diabetes in a Nationwide Cohort Study.
PubMed 文献 · Clin Gastroenterol Hepatol · 2019-08-05

IBD患者2型糖尿病标准化发病比(SIR)为1.54(95%CI 1.49-1.60),克罗恩病与溃疡性结肠炎均升高,诊断后第一年风险最高(SIR 4.48),2003-2014年诊断者风险高于更早年代。

要点

  • IBD患者2型糖尿病风险显著升高,总体SIR 1.54(95%CI 1.49-1.60)。
  • 诊断后第一年风险最高(SIR 4.48),20年后仍升高(SIR 1.26)。
  • 2003-2014年诊断IBD者SIR 1.79,高于1977-1988年(1.47)和1989-2002年(1.48)。

核心结论

  • 基于人群的队列研究发现溃疡性结肠炎或克罗恩病患者2型糖尿病风险升高,2003-2014年诊断者风险估计值高于更早年份。
  • 需进一步研究确定IBD治疗对2型糖尿病风险的影响。

主要发现

  • 随访736072人年期间,IBD患者发生2型糖尿病3436例,预期2224例(SIR 1.54;95%CI 1.49-1.60)。
  • 溃疡性结肠炎患者SIR 1.54(95%CI 1.48-1.60),克罗恩病患者SIR 1.57(95%CI 1.47-1.67),女性SIR 1.51(95%CI 1.44-1.59),男性SIR 1.57(95%CI 1.50-1.65)。
  • 诊断IBD后第一年风险最高(SIR 4.48;95%CI 4.16-4.83),诊断后20年及以上仍升高(SIR 1.26;95%CI 1.16-1.38)。
  • 2003-2014年诊断IBD者SIR 1.79(95%CI 1.67-1.91),高于1977-1988年诊断者SIR 1.47(95%CI 1.39-1.56)和1989-2002年诊断者SIR 1.48(95%CI 1.41-1.56)(P < .001)。
  • 风险升高不能由就医频率或皮质类固醇暴露解释。

关键数值与推荐

  • IBD患者2型糖尿病总体SIR 1.54(95%CI 1.49-1.60)。
  • 诊断后第一年SIR 4.48(95%CI 4.16-4.83),20年及以上SIR 1.26(95%CI 1.16-1.38)。
  • 2003-2014年诊断者SIR 1.79(95%CI 1.67-1.91),1977-1988年诊断者SIR 1.47(95%CI 1.39-1.56),1989-2002年诊断者SIR 1.48(95%CI 1.41-1.56),组间P < .001。

临床怎么用

  • IBD患者2型糖尿病风险升高,诊断后第一年及长期随访中均需关注。
  • 2003-2014年诊断IBD者2型糖尿病风险估计值高于更早年份。

局限性

  • 原文未述局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND & AIMS: The intestine regulates glucose homeostasis, but it is not clear whether chronic intestinal inflammation affects risk for type 2 diabetes. We investigated the long-term risk of type 2 diabetes in patients with inflammatory bowel diseases (IBD) in a nationwide cohort study in Denmark. METHODS: In a nationwide population-based cohort of 6,028,844 persons in Denmark, we compared data from individuals with a diagnosis of IBD (Crohn's disease [CD] or ulcerative colitis UC]) with data from individuals from the general population from 1977 through 2014. Persons with type 2 diabetes were identified in the National Patient Register. Risk is presented as standardized incidence ratios (SIR) with 95% CIs. RESULTS: During 736,072 person-years of follow-up, 3436 patients with IBD developed type 2 diabetes vs 2224 expected (SIR, 1.54; 95% CI, 1.49-1.60). The risk was significantly increased in patients with UC (SIR, 1.54; 95% CI, 1.48-1.60), in patients with CD (SIR, 1.57; 95% CI, 1.47-1.67), in women (SIR, 1.51; 95% CI, 1.44-1.59), and in men (SIR, 1.57; 95% CI, 1.50-1.65). The risk was highest the first year after a diagnosis of IBD (SIR, 4.48; 95% CI, 4.16-4.83), but remained increased for 20 or more years following the diagnosis (SIR, 1.26; 95% CI, 1.16-1.38). The increased risk could not be accounted for by frequency of health care contacts or corticosteroid exposure. Patients who received a diagnosis of IBD from 2003 through 2014 (SIR, 1.79; 95% CI, 1.67-1.91) had a significantly higher risk of type 2 diabetes than patients who received a diagnosis of IBD from 1977 through 1988 (SIR, 1.47; 95% CI, 1.39-1.56) or 1989 through 2002 (SIR, 1.48; 95% CI, 1.41-1.56) (P < .001). CONCLUSIONS: In a population-based cohort study, we found an increased risk of type 2 diabetes in patients with UC or CD, with highest risk estimates from 2003 through 2014, compared with earlier years. Studies are needed to determine the effects of IBD treatment on risk of type 2 diabetes.

来源:Clin Gastroenterol Hepatol,查看原文。版权归原作者所有。

引用

  1. Jess T, Jensen BW, Andersson M, et al. Inflammatory Bowel Diseases Increase Risk of Type 2 Diabetes in a Nationwide Cohort Study. Clin Gastroenterol Hepatol. 2019. PMID: 31394285. doi:10.1016/j.cgh.2019.07.052

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。